Pretreatment with antithrombotic agents during radiofrequency catheter ablation: A randomized comparison of aspirin versus ticlopidine

Journal of Cardiovascular Electrophysiology

Volumn 9, Issue 11, 1998, Pages 1144-1151

  Manolis, Antonis S ^a,b,c   Maounis, Themos ^a   Vassilikos, Vassilis ^a   Melita Manolis, Helen ^a   Psarros, Lefteris ^a   Terzoglou, George ^a   Cokkinos, Dennis V ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c Department of Cardiology ^*  (Greece)

Author keywords

Ablation; Aspirin; D dimer; Radiofrequency current; Thrombosis; Ticlopidine

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; D DIMER; TICLOPIDINE;

ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD LEVEL; CATHETER ABLATION; CHILD; DRUG SAFETY; ELECTROPHYSIOLOGY; FEMALE; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; THROMBOEMBOLISM; THROMBOGENESIS; THROMBOGENICITY;

EID: 0031768435     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1998.tb00085.x     Document Type: Article

References (20)

1. Scheinman MM: NASPE survey on catheter ablation. PACE 1995;18:1474-1478.
2. Manolis AS, Wang PJ, Estes NAM III: Radiofrequency catheter ablation for cardiac tachyarrhythmias. Ann Intern Med 1994;121:452-461.
3. Kuck K-H, Schlueter M, Geiger M, et al: Radiofrequency current catheter ablation of accessory atrioventricular pathways. Lancet 1991;337:1557-1561.
4. Manolis AS, Wang PJ, Estes NAM III: Radiofrequency ablation of slow pathway in patients with atrioventricular nodal reentrant tachycardia: Do arrhythmia recurrences correlate with persistent slow pathway conduction or site of successful ablation? Circulation 1994;90:2815-2819.
5. Manolis AS, Wang PJ, Estes NAM III: Radiofrequency ablation of left-sided accessory pathways: Transaortic versus transseptal approach. Am Heart J 1994;128:896-902.
6. Calkins H, Langberg JJ, Sousa J, et al: Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Circulation 1992;85:1337-1346.
7. Lesh MD, Van Hare GF, Schamp DJ, et al: Curative percutaneous catheter ablation using radiofrequency energy for accessory pathways in all locations: Results in 100 consecutive patients. J Am Coll Cardiol 1992;19:1303-1309.
8. Kay GN, Epstein AE, Dailey SM, et al: Role of radiofrequency ablation in the management of supraventricular arrhythmias: Experience in 760 consecutive patients. J Cardiovasc Electrophysiol 1993;4:371-389.
9. Saul JP, Hulse JE, De W, et al: Catheter ablation of accessory atrioventricular pathways in young patients: Use of long vascular sheaths, the transseptal approach and a retrograde left posterior parallel approach. J Am Coll Cardiol 1993;21:571-583.
10. Goli VD, Prasad R, Hamilton K, et al: Transesophageal echocardiographic evaluation for mural thrombus following radiofrequency catheter ablation of accessory pathways. PACE 1991;14:1992-1997.
11. Thakur RK, Klein GJ, Yee R, et al: Embolic complications following radiofrequency catheter ablation in the left heart. (Abstract) Circulation 1993;88: I-296.
12. Hindricks G: The Multicentre European Radiofrequency Survey (MERFS): Complications of radiofrequency catheter ablation of arrhythmias. Eur Heart J 1993;14:1644-1653.
13. Thakur RK, Klein GJ, Yee R: Embolic complications in Multicentre European Radiofrequency Survey (MERFS). (Letter to the Editor) Eur Heart J 1994;15:1290.
14. Manolis AS, Melita-Manolis H, Vassilikos V, et al: Thrombogenicity of radiofrequency lesions: Results with serial D-dimer determinations. J Am Coll Cardiol 1996;28:1257-1261.
15. Manolis AS, Vassilikos V, Maounis T, et al: Pre-treatment with aspirin and ticlopidine confers lower thrombogenic potential of radiofrequency catheter ablation. Am J Cardiol 1997;79:494-497.
16. Wang T-L, Lin J-L, Hwang J-J, et al: The evolution of platelet aggregability in patients undergoing catheter ablation for supraventricular tachycardia with radiofrequency energy: The role of antiplatelet therapy. PACE 1995;18:1980-1990.
17. Hall P, Nakamura S, Maiello L, et al: A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996;93:215-222.
18. Neumann F-J, Gawaz M, Dickfeld T, et al: Antiplatelet effect of ticlopidine after coronary stenting. J Am Coll Cardiol 1997;29:1515-1519.
19. Haïssaguerre M, Jais P, Shah D, et al: Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1996;7:1132-1144.
20. Olgin JE, Sih HJ: Ablation of atrial fibrillation. J Cardiovasc Electrophysiol 1997;8:1266-1268.